NEW YORK, Nov. 20 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb today announced the results of the tender offer for its 5.75% notes due October 1, 2011, which closed at 5:00 p.m. New York Time, on Friday, November 17, 2006.
In aggregate $1,817,892,000 principal amount of notes was tendered in the offer. Bristol-Myers Squibb will repurchase all notes validly tendered for settlement November 27, 2006. The offer was contingent upon meeting certain conditions described in the Offer to Purchase dated November 9, 2006, including the Financing Condition. All of the conditions have been met.
As announced on November 16, 2006, Bristol-Myers Squibb will pay $1,037.16 plus $8.94 of accrued interest per $1,000 principal amount tendered.
CUSIP Title of Security Principal Amount Principal Amount Outstanding Tendered 110122AG3 5.75% Notes due October 11, 2011 $2,500,000,000 $1,817,892,000
Bristol-Myers Squibb Company is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
Bristol-Myers Squibb
CONTACT: Media, Tony Plohoros, +1-212-546-4379, tony.plohoros@bms.com, orJeff Macdonald, +1-212-546-4824, jeffrey.macdonald@bms.com, or Investors,John Elicker, +1-212-546-3775, john.elicker@bms.com, or Blaine Davis,+1-212-546-4631, blaine.davis@bms.com, all for Bristol-Myers Squibb
Web site: http://www.bms.com/
